Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
MLN4924 HCl Salt: A Translational Lens on RIPK3
2026-09-29
Neddylation connects protein turnover, viral immune evasion, and inflammatory cell death. This thought-leadership article explains how MLN4924 HCl salt can help translational researchers test whether cullin-RING ligase activity is required for viral RIPK3 degradation, while distinguishing established evidence from forward-looking hypotheses.
-
Ceramides Drive RGNNV Replication Through Autophagy
2026-09-29
This study uses global lipidomics and pathway perturbation to show that red-spotted grouper nervous necrosis virus reshapes ceramide metabolism and exploits ceramide-dependent autophagy for replication. Its combination of lipid profiling, capsid-protein localization, genetic and pharmacological inhibition, and C16-ceramide rescue provides a useful framework for interpreting lipid–virus interactions while defining clear limits for cross-system translation.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow Guide
2026-09-28
Build a transient CRISPR-Cas9 workflow around Cap1-capped, m1Ψ-modified Cas9 mRNA for genome editing in mammalian cells. This guide connects practical RNA handling, delivery optimization, immune-response monitoring, and emerging chemical delivery strategies for CNS research without overstating product validation.
-
GDC-0068 (RG7440): An Akt–mTOR Workflow
2026-09-28
Use GDC-0068 (RG7440) to test how pan-Akt inhibition reshapes PI3K/Akt/mTOR signaling in cancer models, while distinguishing pathway output from changes in phospho-Akt abundance. Pair this upstream perturbation with spatially targeted mTORC1 approaches to separate broad pathway dependence from compartment-specific biology.
-
Olsalazine Sodium: Practical Cancer Research Workflows
2026-09-27
Olsalazine Sodium is a water-soluble mesalamine dimer that supports both LTB4-driven inflammation assays and colorectal cancer model studies. This guide connects reported activity with practical dosing, workflow design, and troubleshooting—including an important distinction between cancer biology applications and a separate mosquito xenobiotic-transport study.
-
EZ Cap™ Cas9 mRNA (m1Ψ) in Cell Viability Workflows
2026-09-26
Learn how to interpret viability and proliferation results when testing CRISPR-Cas9 genome editing in mammalian cells. This scenario-based guide covers controls, RNA handling, protocol limits, and selection considerations for EZ Cap™ Cas9 mRNA (m1Ψ), SKU R1014.
-
EdU Imaging Kits (Cy3) for Bladder Cancer Assays
2026-09-25
Turn S-phase DNA synthesis into a clear, cell-resolved readout for bladder cancer experiments with EdU Imaging Kits (Cy3). The click-chemistry workflow avoids DNA denaturation, making it useful when morphology and compatible downstream staining matter—but EdU signal should be interpreted as a snapshot of DNA synthesis, not as a stand-alone measure of anoikis or cell death.
-
TMRE mitochondrial membrane potential assay kit for NECSO
2026-09-25
Track mitochondrial depolarization during sodium-overload experiments with a red fluorescent readout and a built-in CCCP control. This practical workflow shows how to use TMRE as one part of a stronger evidence chain—not as a stand-alone measure of sodium, ATP, or cell death.
-
Bradykinin BA5201: Practical Research Guide
2026-09-24
Bradykinin (BA5201) provides a defined peptide input for research on endothelium-dependent vasodilation, vascular permeability, smooth muscle contraction, and pain or inflammatory responses. This guide covers handling and assay design; the product is for scientific research only, not diagnostic or medical use, and no universal dose or response is specified.
-
EdU Imaging Kits (Cy3) for Mesangial Cell Studies
2026-09-24
Connect mesangial-cell biology to a direct readout of DNA synthesis with a denaturation-free EdU workflow suited to microscopy and flow cytometry. Practical controls and optimization guidance help distinguish changes in S-phase entry from changes in cell number or tissue morphology.
-
Chronic Stress, Brain Mitochondria, and MnTBAP Rescue
2026-09-23
A 2025 rat study links chronic unpredictable mild stress with mitochondrial dysfunction and elevated inflammatory cytokines in the hippocampus and prefrontal cortex. Intracerebroventricular MnTBAP alleviated stress-associated depression-like behavior, supporting a role for mitochondrial processes in the model while leaving important questions about mechanism, dosing, and clinical relevance open.
-
cck8 Cell Viability Workflow for Senolysis
2026-09-23
Build a reproducible CCK-8 workflow for distinguishing loss of viable renal tubular epithelial cells from changes in cellular metabolism. This guide translates GLS1-inhibition senolysis findings into practical plate design, controls, optimization steps, and troubleshooting for cell proliferation and cytotoxicity studies.
-
(-)-Arctigenin and the EV–NF-κB Metastasis Axis
2026-09-22
Tumor-associated macrophage extracellular vesicles can convert inflammatory signaling into a metastasis-supportive program. This article examines how (-)-Arctigenin may serve as a mechanistically informed research tool for interrogating the KLHL21–IKKβ–NF-κB p65 axis, while distinguishing established evidence from translational hypotheses.
-
Exemestane: From Enzyme Inhibition to Assay Insight
2026-09-22
Exemestane is a steroidal aromatase inhibitor whose irreversible mechanism offers a powerful lens for studying estrogen biosynthesis and endocrine response. This article connects molecular pharmacology with assay design, breast cancer research, and the clinical context of selective estrogen receptor modulation.
-
KPT330 and CRISPR-Cas9 Precision Editing
2026-09-21
The reference study identifies selective inhibitors of nuclear export, including KPT330, as indirect modulators that reduce Cas9 activity by disrupting Cas9 mRNA export rather than directly blocking the nuclease. Its findings suggest that controlling the duration and localization of Cas9 expression can improve genome- and base-editing specificity in mammalian cells, while also highlighting important translational and safety limitations.